Semaglutide has become one of the most talked-about medications in...
Read More
FDA-approved GLP-1 medications prescribed by licensed physicians, delivered to your door. No waiting rooms, no prior diagnosis required.
Available as: Ozempic®, Wegovy®, Rybelsus®, or Compounded
Semaglutide is a GLP-1 receptor agonist that mimics the body's natural gut hormone to reduce hunger, slow digestion, and regulate blood sugar. Originally developed for type 2 diabetes (Ozempic®), higher-dose semaglutide was FDA-approved for chronic weight management as Wegovy® in 2021. It is the most prescribed GLP-1 weight loss medication in the world.
Our licensed physicians prescribe semaglutide as a weekly injectable or once-daily oral tablet (Rybelsus®), based on your preference and clinical profile. Compounded semaglutide is available at a significantly reduced cost.
Brand names & forms available:
Available as: Mounjaro®, Zepbound™, Oral Tirzepatide, or Compounded
Tirzepatide is the most advanced GLP-1 weight loss medication available today. Unlike semaglutide, which targets only the GLP-1 receptor, tirzepatide is a dual agonist — activating both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously. This dual action produces significantly greater weight loss results in clinical trials.
FDA-approved as Mounjaro® for diabetes and Zepbound™ specifically for weight loss, tirzepatide is also available as an oral subscription or compounded formulation through our licensed physician network.
Brand names & forms available:
Prefer a pill over an injection? We offer oral formulations of both semaglutide and tirzepatide — just as effective, easier to take.
Rybelsus® | Compounded Oral
Semaglutide in pill form, taken once daily. Rybelsus® is the only FDA-approved oral GLP-1 for weight management. Compounded oral semaglutide is also available at a lower cost. Ideal for patients who prefer to avoid injections.
Compounded Oral Tirzepatide
Experience the power of tirzepatide's dual GLP-1/GIP action in a convenient once-daily oral formulation. Available as a compounded oral medication prescribed by our licensed physicians. Brand-name oral options available at extra cost.
Choose Injectable if:
You want maximum absorption, don't mind weekly injections, or want the largest dose options.
Choose Oral if:
You have needle aversion, prefer a daily pill routine, or are just starting your weight loss journey.
Available as: Saxenda® (weight) · Victoza® (diabetes)
Liraglutide is a once-daily injectable GLP-1 receptor agonist with over a decade of clinical use. FDA-approved as Saxenda® for chronic weight management in 2014, it was one of the first GLP-1 medications approved specifically for obesity treatment in adults and adolescents (12+).
While newer medications like semaglutide and tirzepatide tend to produce greater average weight loss, liraglutide remains a clinically valid option and may be preferred for certain patients based on their health history, prior medication experience, or tolerance.
Not sure which medication is right for you? Compare them side by side — your physician will make the final recommendation.
| Feature | Semaglutide | Tirzepatide | Oral Semaglutide | Oral Tirzepatide | Liraglutide |
|---|---|---|---|---|---|
| Drug class | GLP-1 agonist | GLP-1 + GIP dual | GLP-1 agonist | GLP-1 + GIP dual | GLP-1 agonist |
| Administration | Weekly injection | Weekly injection | Daily oral pill | Daily oral pill | Daily injection |
| Avg. weight loss | ~15% | Up to 22.5% | ~10–12% | ~15–20% | ~8% |
| FDA approved | ✓ 2021 | ✓ 2023 | ✓ (Rybelsus®) | Compounded | ✓ 2014 |
| Brand available | ✓ Ozempic/Wegovy | ✓ Mounjaro/Zepbound | ✓ Rybelsus® | Extra cost | ✓ Saxenda® |
| Compounded option | ✓ | ✓ | ✓ | ✓ | — |
| Needle-free option | — | — | ✓ | ✓ | — |
| Starting price | $299/mo | $399/mo | $299/mo | $399/mo | Consult for pricing |
| Multi-month package | ✓ | ✓ | ✓ | — | — |
| Cancel anytime | ✓ | ✓ | ✓ | ✓ | ✓ |
* Average weight loss figures based on pivotal clinical trials. Individual results vary. Physician evaluation required for all Rx.
Our telemedicine process is fast, private, and designed to get you from consultation to prescription as smoothly as possible.
Schedule your no-cost introductory call with our care team. Zero obligation, zero pressure.
A licensed physician reviews your health history, BMI, and goals via secure telemedicine visit.
Your physician issues your personalized prescription — injectable or oral, brand or compounded.
Your medication ships from a licensed pharmacy directly to your door. Ongoing monthly support included.
Eligibility is determined by a licensed physician during your clinical evaluation. These are the general guidelines.
Book your free consultation and our care team will help you understand your options — no commitment required.
GLP-1 medications are well-tolerated by most patients. Side effects are typically mild, most common at the start of treatment, and improve as your body adjusts.
Most common at the start or after dose increases. Usually mild and subsides within 2–4 weeks. Eating smaller meals helps.
GI motility changes are common. Staying hydrated and maintaining dietary fiber intake helps manage symptoms.
Bloating, fullness, or mild abdominal pain — especially after eating. Typically resolves as your body adjusts to medication.
Intentional effect of GLP-1 medications. Leads to reduced caloric intake. Ensure you're still meeting nutritional needs.
Usually dose-related. Our physicians titrate doses gradually to minimize this risk. Report persistent vomiting promptly.
Low blood sugar risk is low in non-diabetic patients. Risk increases if combined with other diabetes medications.
Mild redness or swelling at the injection site. Rotate injection sites to minimize. Resolves quickly in most cases.
Very rare but serious. Stop medication and contact your physician immediately if you experience severe abdominal pain.
Important: This is a general overview and not a complete list of side effects. Your physician will review your full health history and explain all relevant risks during your clinical evaluation. Always follow your physician's dosing instructions and report any unusual symptoms promptly.
No hidden fees. Cancel anytime. Multi-month packages save you more.
Clear answers to the most common questions about semaglutide, tirzepatide, and our telemedicine treatment programs.
Clinical trials show tirzepatide produces greater average weight loss (up to 22.5% vs ~15% for semaglutide). However, the right choice depends on your health history, tolerance, and cost preference. Your physician will guide you.
Both contain semaglutide. Ozempic® is FDA-approved for type 2 diabetes and comes in lower doses. Wegovy® is FDA-approved specifically for weight management and uses higher doses designed for obesity treatment.
Yes. Our physicians will monitor your progress and can adjust your medication, dose, or formulation if your initial treatment isn't producing results or is causing intolerable side effects.
Most patients notice reduced appetite within the first 1–2 weeks. Meaningful weight loss typically becomes visible at 4–8 weeks. Maximum results are usually seen at 12–18 months of consistent treatment.
Research suggests many patients regain weight after stopping GLP-1 therapy, as the medication controls hunger signals. This is why ongoing lifestyle changes alongside medication are important. Your physician will create a long-term plan.
Compounded GLP-1 medications contain the same FDA-approved active ingredients (semaglutide or tirzepatide) but are prepared by state-licensed compounding pharmacies, allowing for lower pricing. They are not FDA-approved end products themselves.
GLP-1 medications are most effective when combined with a reduced-calorie diet and increased physical activity. Your physician will help you create a sustainable lifestyle plan alongside your medication.
Our clinical evaluations are conducted via secure video or asynchronous questionnaire, depending on your state and preference. All visits are HIPAA-compliant and conducted by licensed physicians.
Book a free consultation and let a licensed physician guide you to the medication that fits your health profile, goals, and budget.
🎁 Start My Free Consultation →* Clinical trial results cited are from published research (STEP 1, SURMOUNT-1, and related trials). Individual outcomes vary based on dose, adherence, diet, exercise, and health history. This page is for informational purposes only and does not constitute medical advice. All treatment requires a licensed physician evaluation. Not all patients will qualify for GLP-1 therapy. Compounded medications use FDA-approved active ingredients but are not themselves FDA-approved end products. Brand-name medications available at extra cost. ©2025 Fast Medical Weight Loss. HIPAA Compliant. All Rights Reserved.
©2026 All Rights Reserved. fastmedicalweightloss.org
